Cargando…
Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study
OBJECTIVE: To study data about SARS-CoV-2 virus shedding and clarify the risk factors for prolonged virus shedding. METHODS: Data were retrospectively collected from adults hospitalized with laboratory-confirmed coronavirus disease-19 (COVID-19) in Wuhan Union Hospital. We compared clinical features...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Huazhong University of Science and Technology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436017/ https://www.ncbi.nlm.nih.gov/pubmed/34515914 http://dx.doi.org/10.1007/s11596-021-2434-y |
_version_ | 1783751917996867584 |
---|---|
author | He, Xin-liang Zhou, Ya-ya Fu, Wei Xue, Yu-e Liang, Meng-yuan Yang, Bo-han Ma, Wan-li Zhou, Qiong Chen, Long Zhang, Jian-chu Wang, Xiao-rong |
author_facet | He, Xin-liang Zhou, Ya-ya Fu, Wei Xue, Yu-e Liang, Meng-yuan Yang, Bo-han Ma, Wan-li Zhou, Qiong Chen, Long Zhang, Jian-chu Wang, Xiao-rong |
author_sort | He, Xin-liang |
collection | PubMed |
description | OBJECTIVE: To study data about SARS-CoV-2 virus shedding and clarify the risk factors for prolonged virus shedding. METHODS: Data were retrospectively collected from adults hospitalized with laboratory-confirmed coronavirus disease-19 (COVID-19) in Wuhan Union Hospital. We compared clinical features among patients with prolonged (a positive SARS-CoV-2 RNA on day 23 after illness onset) and short virus shedding and evaluated risk factors associated with prolonged virus shedding by multivariate regression analysis. RESULTS: Among 238 patients, the median age was 55.5 years, 57.1% were female, 92.9% (221/238) were administered with arbidol, 58.4% (139/238) were given arbidol in combination with interferon. The median duration of SARS-CoV-2 virus shedding was 23 days (IQR, 17.8–30 days) with a longest one of 51 days. The patients with prolonged virus shedding had higher value of D-dimer (P=0.002), IL-6 (P<0.001), CRP (P=0.005) and more lobes lung lesion (P=0.014) on admission, as well as older age (P=0.017) and more patients with hypertension (P=0.044) than in those the virus shedding less than 23 days. Multivariate regression analysis revealed that prolonged viral shedding was significantly associated with initiation arbidol >8 days after symptom onset [OR: 2.447, 95% CI (1.351–4.431)], ≥3 days from onset of symptoms to first medical visitation [OR: 1.880, 95% CI (1.035–3.416)], illness onset before Jan. 31, 2020 [OR: 3.289, 95% CI (1.474–7.337)]. Arbidol in combination with interferon was also significantly associated with shorter virus shedding [OR: 0.363, 95% CI (0.191–0.690)]. CONCLUSION: Duration of SARS-CoV-2 virus shedding was long. Early initiation of arbidol and arbidol in combination with interferon as well as consulting doctor timely after illness onset were helpful for SARS-CoV-2 clearance. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s11596-021-2434-y and is accessible for authorized users. |
format | Online Article Text |
id | pubmed-8436017 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Huazhong University of Science and Technology |
record_format | MEDLINE/PubMed |
spelling | pubmed-84360172021-09-13 Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study He, Xin-liang Zhou, Ya-ya Fu, Wei Xue, Yu-e Liang, Meng-yuan Yang, Bo-han Ma, Wan-li Zhou, Qiong Chen, Long Zhang, Jian-chu Wang, Xiao-rong Curr Med Sci Article OBJECTIVE: To study data about SARS-CoV-2 virus shedding and clarify the risk factors for prolonged virus shedding. METHODS: Data were retrospectively collected from adults hospitalized with laboratory-confirmed coronavirus disease-19 (COVID-19) in Wuhan Union Hospital. We compared clinical features among patients with prolonged (a positive SARS-CoV-2 RNA on day 23 after illness onset) and short virus shedding and evaluated risk factors associated with prolonged virus shedding by multivariate regression analysis. RESULTS: Among 238 patients, the median age was 55.5 years, 57.1% were female, 92.9% (221/238) were administered with arbidol, 58.4% (139/238) were given arbidol in combination with interferon. The median duration of SARS-CoV-2 virus shedding was 23 days (IQR, 17.8–30 days) with a longest one of 51 days. The patients with prolonged virus shedding had higher value of D-dimer (P=0.002), IL-6 (P<0.001), CRP (P=0.005) and more lobes lung lesion (P=0.014) on admission, as well as older age (P=0.017) and more patients with hypertension (P=0.044) than in those the virus shedding less than 23 days. Multivariate regression analysis revealed that prolonged viral shedding was significantly associated with initiation arbidol >8 days after symptom onset [OR: 2.447, 95% CI (1.351–4.431)], ≥3 days from onset of symptoms to first medical visitation [OR: 1.880, 95% CI (1.035–3.416)], illness onset before Jan. 31, 2020 [OR: 3.289, 95% CI (1.474–7.337)]. Arbidol in combination with interferon was also significantly associated with shorter virus shedding [OR: 0.363, 95% CI (0.191–0.690)]. CONCLUSION: Duration of SARS-CoV-2 virus shedding was long. Early initiation of arbidol and arbidol in combination with interferon as well as consulting doctor timely after illness onset were helpful for SARS-CoV-2 clearance. ELECTRONIC SUPPLEMENTARY MATERIAL: Supplementary material is available for this article at 10.1007/s11596-021-2434-y and is accessible for authorized users. Huazhong University of Science and Technology 2021-09-13 2021 /pmc/articles/PMC8436017/ /pubmed/34515914 http://dx.doi.org/10.1007/s11596-021-2434-y Text en © Huazhong University of Science and Technology 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Article He, Xin-liang Zhou, Ya-ya Fu, Wei Xue, Yu-e Liang, Meng-yuan Yang, Bo-han Ma, Wan-li Zhou, Qiong Chen, Long Zhang, Jian-chu Wang, Xiao-rong Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study |
title | Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study |
title_full | Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study |
title_fullStr | Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study |
title_full_unstemmed | Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study |
title_short | Prolonged SARS-CoV-2 Viral Shedding in Patients with COVID-19 was Associated with Delayed Initiation of Arbidol Treatment and Consulting Doctor Later: A Retrospective Cohort Study |
title_sort | prolonged sars-cov-2 viral shedding in patients with covid-19 was associated with delayed initiation of arbidol treatment and consulting doctor later: a retrospective cohort study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8436017/ https://www.ncbi.nlm.nih.gov/pubmed/34515914 http://dx.doi.org/10.1007/s11596-021-2434-y |
work_keys_str_mv | AT hexinliang prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT zhouyaya prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT fuwei prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT xueyue prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT liangmengyuan prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT yangbohan prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT mawanli prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT zhouqiong prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT chenlong prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT zhangjianchu prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy AT wangxiaorong prolongedsarscov2viralsheddinginpatientswithcovid19wasassociatedwithdelayedinitiationofarbidoltreatmentandconsultingdoctorlateraretrospectivecohortstudy |